Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Pancreatic Neoplasms 26Carcinoma, Non-Small-Cell Lung 14Breast Neoplasms 14Neoplasm Metastasis 7Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Parkinson Disease 4, Autosomal Dominant Lewy Body 3Neoplasms 3Stomach Neoplasms 2Ovarian Neoplasms 2Metastatic Pancreatic Ductal Adenocarcinoma 2Lung Neoplasms 2Inflammatory Breast Neoplasms 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Unresectable Biliary Tract Cancer 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thromboembolism 1TNBC 1Sarcoma 1Peritoneal Neoplasms 1Oropharyngeal Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Mouth Neoplasms 1Locally Advanced or Metastatic Solid Tumours 1Locally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy 1Lip Neoplasms 1Laryngeal Neoplasms 1Head and Neck Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 7trametinib 5pembrolizumab 5selpercatinib 4dabrafenib 4Specimen Handling 4Nivolumab 4cabozantinib 3Iodine-131 3spartalizumab 2omipalisib 2lenvatinib 2durvalumab 2binimetinib 2Vemurafenib 2Sorafenib 2Ipilimumab 2Immunoglobulin G 2Disulfides 2CTLA-4 Antigen 2Biopsy 2ulixertinib 1trastuzumab biosimilar HLX02 1tislelizumab 1tipifarnib 1sapanisertib 1relatlimab 1regorafenib 1pertuzumab 1palbociclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Thyroid Neoplasms × 130-nm albumin-bound paclitaxel × Clear all
NCT03181100 2026-01-09

Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
50 enrolled
EndocrineHead & Neck

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡